Menu

Best Brands

NORMEGA1000

SKU: Z.177901427862421
|
0 Reviews
Tax-free
Weight:  kg

SAR 66.00

+  

Earn loyalty points with this purchase

Rewards  

Description

Normega … Nutrition for the Heart, Mind, and Body  In a world increasingly filled with stress, poor nutrition, and lack of physical activity, maintaining heart and brain health has become a necessity rather than a luxury. 

This product is out of stock

Notify me when product is available

This product is out of stock

Notify me when product is available

Product Description

NORMEGA 1000
High-Purity Omega-3 For Advanced Lipid Management
EACH 2 SOFTGEL CAPSULES CONTAIN:
EPA 660 mg
DHA 440 mg
RECOMMENDED DOSAGE
Mild to Moderate Hypertriglyceridemia
(TG 150–499 mg/dL)
1–2 g/day
(2–4 softgels)
Severe Hypertriglyceridemia
(TG ≥ 500 mg/dL)
2–4 g/day
(4–8 softgels)
Use as adjunct to diet, exercise, and statin therapy when appropriate.
INDICATIONS
Hypertriglyceridemia
Mixed Dyslipidemia
Cardiovascular Risk Reduction
Metabolic Syndrome
SAFETY PROFILE
Generally well tolerated
Mild GI symptoms (e.g., fishy aftertaste, dyspepsia) in some patients
No significant increase in bleeding risk in clinical studies
No clinically relevant drug interactions
Suitable for long-term use
Quality Features
High Purity
Molecularly Distilled
Heavy Metal Tested
IFOS Compliant
Oxidation Controlled
MECHANISM OF ACTION
Decreases hepatic VLDL-TG synthesis by reducing substrate availability
Inhibits diacylglycerol acyltransferase (DGAT) and apo-CIII expression
Enhances fatty acid β-oxidation and reduces hepatic steatosis
Reduces VLDL secretion and plasma triglyceride levels
Anti-inflammatory effects via reduction of cytokines (IL-6, TNF-α, CRP)
CLINICAL EVIDENCE
MARINE Trial
Hypertriglyceridemia (TG > 500 mg/dL)
n = 229
TG Reduction: 33% with 4 g/day Omega-3 (EPA+DHA)
ANCHOR Trial
TG (200–499 mg/dL) on statin therapy
n = 4448
TG Reduction: 21.5% with 4 g/day Omega-3 (EPA+DHA)

NORMEGA 1000
High-Purity Omega-3 For Advanced Lipid Management
EACH 2 SOFTGEL CAPSULES CONTAIN:
EPA 660 mg
DHA 440 mg
RECOMMENDED DOSAGE
Mild to Moderate Hypertriglyceridemia
(TG 150–499 mg/dL)
1–2 g/day
(2–4 softgels)
Severe Hypertriglyceridemia
(TG ≥ 500 mg/dL)
2–4 g/day
(4–8 softgels)
Use as adjunct to diet, exercise, and statin therapy when appropriate.
INDICATIONS
Hypertriglyceridemia
Mixed Dyslipidemia
Cardiovascular Risk Reduction
Metabolic Syndrome
SAFETY PROFILE
Generally well tolerated
Mild GI symptoms (e.g., fishy aftertaste, dyspepsia) in some patients
No significant increase in bleeding risk in clinical studies
No clinically relevant drug interactions
Suitable for long-term use
Quality Features
High Purity
Molecularly Distilled
Heavy Metal Tested
IFOS Compliant
Oxidation Controlled
MECHANISM OF ACTION
Decreases hepatic VLDL-TG synthesis by reducing substrate availability
Inhibits diacylglycerol acyltransferase (DGAT) and apo-CIII expression
Enhances fatty acid β-oxidation and reduces hepatic steatosis
Reduces VLDL secretion and plasma triglyceride levels
Anti-inflammatory effects via reduction of cytokines (IL-6, TNF-α, CRP)
CLINICAL EVIDENCE
MARINE Trial
Hypertriglyceridemia (TG > 500 mg/dL)
n = 229
TG Reduction: 33% with 4 g/day Omega-3 (EPA+DHA)
ANCHOR Trial
TG (200–499 mg/dL) on statin therapy
n = 4448
TG Reduction: 21.5% with 4 g/day Omega-3 (EPA+DHA)

About the product

NORMEGA 1000
High-Purity Omega-3 For Advanced Lipid Management
EACH 2 SOFTGEL CAPSULES CONTAIN:
EPA 660 mg
DHA 440 mg
RECOMMENDED DOSAGE
Mild to Moderate Hypertriglyceridemia
(TG 150–499 mg/dL)
1–2 g/day
(2–4 softgels)
Severe Hypertriglyceridemia
(TG ≥ 500 mg/dL)
2–4 g/day
(4–8 softgels)
Use as adjunct to diet, exercise, and statin therapy when appropriate.
INDICATIONS
Hypertriglyceridemia
Mixed Dyslipidemia
Cardiovascular Risk Reduction
Metabolic Syndrome
SAFETY PROFILE
Generally well tolerated
Mild GI symptoms (e.g., fishy aftertaste, dyspepsia) in some patients
No significant increase in bleeding risk in clinical studies
No clinically relevant drug interactions
Suitable for long-term use
Quality Features
High Purity
Molecularly Distilled
Heavy Metal Tested
IFOS Compliant
Oxidation Controlled
MECHANISM OF ACTION
Decreases hepatic VLDL-TG synthesis by reducing substrate availability
Inhibits diacylglycerol acyltransferase (DGAT) and apo-CIII expression
Enhances fatty acid β-oxidation and reduces hepatic steatosis
Reduces VLDL secretion and plasma triglyceride levels
Anti-inflammatory effects via reduction of cytokines (IL-6, TNF-α, CRP)
CLINICAL EVIDENCE
MARINE Trial
Hypertriglyceridemia (TG > 500 mg/dL)
n = 229
TG Reduction: 33% with 4 g/day Omega-3 (EPA+DHA)
ANCHOR Trial
TG (200–499 mg/dL) on statin therapy
n = 4448
TG Reduction: 21.5% with 4 g/day Omega-3 (EPA+DHA)

Total Products

SAR 66.00

Multiple payment methods

and safe

NORMEGA 1000
High-Purity Omega-3 For Advanced Lipid Management
EACH 2 SOFTGEL CAPSULES CONTAIN:
EPA 660 mg
DHA 440 mg
RECOMMENDED DOSAGE
Mild to Moderate Hypertriglyceridemia
(TG 150–499 mg/dL)
1–2 g/day
(2–4 softgels)
Severe Hypertriglyceridemia
(TG ≥ 500 mg/dL)
2–4 g/day
(4–8 softgels)
Use as adjunct to diet, exercise, and statin therapy when appropriate.
INDICATIONS
Hypertriglyceridemia
Mixed Dyslipidemia
Cardiovascular Risk Reduction
Metabolic Syndrome
SAFETY PROFILE
Generally well tolerated
Mild GI symptoms (e.g., fishy aftertaste, dyspepsia) in some patients
No significant increase in bleeding risk in clinical studies
No clinically relevant drug interactions
Suitable for long-term use
Quality Features
High Purity
Molecularly Distilled
Heavy Metal Tested
IFOS Compliant
Oxidation Controlled
MECHANISM OF ACTION
Decreases hepatic VLDL-TG synthesis by reducing substrate availability
Inhibits diacylglycerol acyltransferase (DGAT) and apo-CIII expression
Enhances fatty acid β-oxidation and reduces hepatic steatosis
Reduces VLDL secretion and plasma triglyceride levels
Anti-inflammatory effects via reduction of cytokines (IL-6, TNF-α, CRP)
CLINICAL EVIDENCE
MARINE Trial
Hypertriglyceridemia (TG > 500 mg/dL)
n = 229
TG Reduction: 33% with 4 g/day Omega-3 (EPA+DHA)
ANCHOR Trial
TG (200–499 mg/dL) on statin therapy
n = 4448
TG Reduction: 21.5% with 4 g/day Omega-3 (EPA+DHA)

Reviews and Customer opinions
Leave a comment

0.0

Based On (0) Reviews
Excellent
0 Review
Very good
0 Review
Good
0 Review
Average
0 Review
Bad
0 Review
  • Categories |
Reviews and Customer opinions
Leave a comment

0.0

Based On (0) Reviews
Excellent
0 Review
Very good
0 Review
Good
0 Review
Average
0 Review
Bad
0 Review
Enter the product review
Number remaining :

250

Upload

Maximum number of images is 3

Redeem your points for rewards
have Points